Recently, the 2024 Wuzhen Health Conference and the 3rd China OTC Conference (hereinafter referred to as the "Conference") was grandly opened with the theme of "Resilience and Change". This year, Omron Healthcare (hereinafter referred to as "Omron") participated in the conference for the third consecutive year and brought a number of innovative products in the field of circulatory systems to the conference. At the meeting, Omron discussed industry hotspots and development trends with experts, scholars and business leaders around the chronic disease management solutions of MMC Health Convenience Store, actively offered suggestions and suggestions for the high-quality development of the medical and health industry, and contributed to the construction of a healthy China. At the same time, Omron has won many awards such as "China Pharmaceutical Industry Influential Person Award" and "Star Single Product Award" in one fell swoop by virtue of its outstanding industry contributions and product advantages in the field of chronic disease management.
Omron (Booth No. V01) brought innovative products and chronic disease solutions to the Wuzhen Health Conference for three consecutive years
Insight into the needs of patients and leading the era of healthy "heart".
At present, in the context of the continuous increase in the incidence and mortality of cardiovascular diseases, Omron has expanded its business to the field of "early detection and postoperative management of atrial fibrillation", with continuous innovation, rich and diversified ECG product matrix, to meet the escalating health needs of patients, and to respond to the call of the "Healthy China Action - Implementation Plan for the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (2023-2030)" with practical actions.
At this conference, Omron brought new products such as atrial fibrillation risk warning sphygmomanometer, ECG sphygmomanometer (electronic sphygmomanometer that can measure electrocardiogram at the same time) and wireless ECG recorder. These three new products cover from early screening of atrial fibrillation to daily postoperative management, effectively helping hypertensive patients to detect the risk of recurrence of atrial fibrillation in time on the basis of daily monitoring of blood pressure. Among them, the atrial fibrillation risk indicator sphygmomanometer can detect the risk of atrial fibrillation with only one measurement, the ECG sphygmomanometer has made a breakthrough in bringing the monitoring methods that were originally only carried out in hospitals to the home, and the radio recorder has its exquisite body design to assist users to efficiently record ECG and analyze the risk of atrial fibrillation.
Focusing on the cardiovascular and cerebrovascular fields, a number of new Omron products were unveiled
Embrace China's opportunities and explore the high-quality development of the industry
As the most innovative and influential health event in China, the conference is not only an important window for Omron to showcase its innovative products, but also provides a good opportunity for it to discuss new models of chronic disease management with industry colleagues. On the opening day of the conference, Ms. Ayumu Okada, President of Omron Health Care Co., Ltd., also attended the opening ceremony as an important guest, further demonstrating Omron's commitment to deeply cultivating the Chinese market and jointly promoting the development of the industry.
In recent years, in order to better overcome the problems of high incidence of chronic diseases and insufficient supply and demand of medical resources, Omron has actively promoted the management of chronic diseases and continued to build an intelligent chronic disease management system with scientific and technological innovation. At this conference, Omron focused on MMC Health Convenience Store, a "one-stop chronic disease detection and consultation convenient service at the doorstep", and focused on showing the audience the project background, the latest progress and the new standardized operation and management services. Mr. Zhao Yao, Director and General Manager of Omron Healthcare (China) Co., Ltd., talked about Omron's vision in chronic disease management at the Health Industry Integration and Development Forum: through the integration of multiple scenarios such as hospitals, families, pharmacies, enterprises, and communities, based on the MMC model, open up medical and health information and services inside and outside the hospital, build an overall and efficient chronic disease management system, and help the transformation of traditional pharmacies and empower the upgrading of the industry. At the Pharmaceutical Internationalization Forum, Ms. Jia Na, Director of Strategic Development Department of Omron Healthcare (China) Co., Ltd., shared the standardized operation and management services of MMC Health Convenience Store. The project has further opened up medical resources inside and outside the hospital, upgraded digital chronic disease management services, and helped achieve continuous health management, professional medical services and digital patient operations.
Mr. Zhao Yao delivered a speech on "Professional Path and Innovation Model of Chronic Disease Management in Chain Pharmacies" at the Health Industry Integration and Development Forum
What's more worth mentioning is that this year, Omron continued to win six awards in one fell swoop with its strong influence, brand power and product power. Among them, Ms. Ayumu Okada, President of Omron Healthcare Co., Ltd., was awarded the "West Lake Award: Influential Person in China's Pharmaceutical Industry", Mr. Zhao Yao, Director and General Manager of Omron Healthcare (China) Co., Ltd., was awarded the "West Lake Award: Outstanding Person in China's Pharmaceutical Industry", Ms. Jia Na, Director of Strategic Development Department of Omron Healthcare (China) Co., Ltd., was awarded the "West Lake Award: Pioneer of China's Pharmaceutical Industry", and the new generation of Omron Electronic Blood Pressure Monitor (HEM-7265T2) won the "West Lake Award· The most popular star item in pharmacies";" "Ou Xiaolong" won the "West Lake Award - Most Creative IP Award". In addition, Omron will also be awarded the "2024 Wuzhen Health Conference · VIP Strategic Cooperation Enterprise". These honors are not only a recognition of Omron's innovative products and services, but also an encouragement to Omron's persistent exploration in the field of chronic disease management.
Omron has won a number of awards (some trophies) for its outstanding advantages and contributions to the healthcare industry
Mr. Yao Zhao, Director & General Manager of Omron Healthcare (China) Co., Ltd., said, "The Wuzhen Health Conference is an annual feast of ideas that links the entire industry chain and leads the transformation of the industry. As an expert in chronic disease management solutions, Omron is honored to participate in it for three consecutive years, deepen exchanges with industry partners, and receive strong support and high recognition from the industry. In the future, Omron will continue to play a leading role in the conference, work with partners to promote the steady realization of the 'Healthy China 2030' strategy, and make greater contributions to the health and well-being of patients." ”
Source: Yigu Network